#TRST2616757VFrance Plans to Extend Pharma Industry Agreement on Employment of People with Disabilities
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The measure would make a collective agreement on employment of people with disabilities mandatory across the French pharmaceutical industry. If adopted, it would apply to all employers and employees covered by the national collective agreement for the sector, not only to the organizations that signed it. Interested parties have 15 days to submit comments. Representative employer organizations have one month to formally oppose the extension with written reasons.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Starts the process to extend a collective agreement on employment of people with disabilities across the pharmaceutical industry
- Would make the agreement mandatory for all covered employers and employees if the extension order is adopted
- Opens a 15-day comment period and a one-month opposition period for representative employer organizations
Obligations
What this law requires
Interested organizations and persons that submit observations or opinions on the proposed extension must send their communications to the Ministry of Labour and Solidarities, DGT, bureau DS1, 14 avenue Duquesne, 75350 Paris SP 07.
Representative employer professional organizations at the level of the agreement that oppose the extension must submit a written, reasoned opposition and notify and file it under the procedures in Labour Code articles L. 2231-5 and L. 2231-6.